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Abstract
Background—Lead exposure has been linked to impaired renal function and kidney failure. 
High lead exposures have been associated with increased mortality from certain cancers, 
hypertension, cardiovascular disease, and amyotrophic lateral sclerosis (ALS).
Methods—We extended vital status follow-up on a cohort of 1,990 lead smelter workers by 25 
years and computed standardized mortality ratios and rate ratios (RR) stratified by cumulative lead 
exposure.
Results—The update added 13,823 person-years at risk and 721 deaths. Increased risk of 
mortality was observed for the a priori outcomes of lung cancer, cardiovascular disease (including 
cerebrovascular disease), chronic kidney disease, and ALS. However, of these outcomes, only 
cardiovascular, cerebrovascular, and chronic kidney diseases were associated with a positive 
exposure-response in RR analyses.
Conclusions—This study reaffirms the association of lead exposure with cardiovascular and 
kidney diseases; however, increased mortality observed for certain cancers is not likely to be due 
to lead exposure.
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INTRODUCTION
Lead is a well-established nephrotoxin and high exposures can result in impaired renal 
function and kidney failure [Ekong et al., 2006]. Other chronic effects of lead exposure are 
less clear. For many years lead has been variously implicated to increased morbidity and 
mortality from other chronic diseases including certain cancers [Steenland and Bofetta, 
2000], and hypertension and cardiovascular disease [Navas-Acien et al., 2007]. In addition, a 
recent meta-analysis of studies examining the association between occupational exposure to 
lead and amyotrophic lateral sclerosis (ALS) reported that workers exposed to lead had an 
81% increased risk of developing ALS [Wang et al., 2014].
Two previous studies of a cohort of lead smelter workers in Idaho [Selevan et al., 1985; 
Steenland et al., 1992] observed excess mortality from chronic kidney disease, 
cerebrovascular diseases, nonmalignant respiratory diseases, kidney cancer, and accidents. 
However, the authors noted the excesses of nonmalignant respiratory disease and accidents 
were likely due to the large number of workers that also worked in the mining industry and 
not lead exposure.
The purpose of this paper is to: (i) update the mortality experience of this cohort and (ii) 
evaluate associations between mortality and cumulative lead exposure using a more refined 
job exposure matrix based on lead exposure measurements taken at the lead smelter plant 
that were not previously considered. The a priori outcomes of interest in this update are: 
cancers of the lung, kidney, and stomach; cardiovascular diseases (including cerebrovascular 
disease and hypertension); renal diseases; and ALS.
METHODS
Cohort
The cohort definition includes all white male hourly workers employed for at least 1 year at 
an Idaho lead smelter plant with at least 1 day of employment between 1940 and 1965 at the 
smelter. The cohort, followed initially through 1977 [Selevan et al., 1985] and subsequently 
through 1988 [Steenland et al., 1992] has been previously described. Details of the cohort 
demographics and work history can be found in Table I.
Mortality
Names of cohort members considered alive as of 1988, or deceased for whom we did not 
have a cause of death, were submitted to the National Death Index (NDI) for determination 
of vital status through 2013. NDI Plus provided underlying and contributing causes of death 
for deceased workers identified by the NDI. All deaths were coded according to the revision 
of the International Classification of Diseases (ICD) in effect at the time of death. Workers 
were considered to be alive as of the study end date of December 31, 2013 as long as they 
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were confirmed alive on January 1, 1979, had a valid (within assigned range) Social Security 
number, and were not shown to be deceased by the NDI. Those not confirmed alive on 
January 1, 1979, with invalid Social Security numbers, and thus not able to be matched with 
the NDI were considered lost to follow-up.
Exposure Assessment
Work history records included beginning and ending dates of employment in 14 lead 
exposed departments (Table II). Records were collected in 1975 and are therefore 
incomplete for 159 workers who were still actively employed in 1975. As a result, these 
individuals work histories were assigned to end on 12/31/1975. The lead smelter ceased 
operations in 1982.
The lead exposure assessment described in the original cohort study was based on exposure 
data collected by the National Institute for Occupational Safety and Health (NIOSH) in 1975 
where a total of 69 lead samples were collected with all 14 departments represented. For 
analysis purposes, exposure was defined at the department level for lead and other heavy 
metal exposures. Two strata were created: high lead and low lead. The high lead stratum 
included nine departments in which average airborne lead concentrations exceeded the 
existing Occupational Safety and Health Administration (OSHA) standard (200 μg/m3 in 
1975) or in which at least 50% of jobs had average levels more than twice the existing 
standard.
For this update, additional exposure records from OSHA were used to develop a more 
refined exposure assessment. These records included air sampling data from four 
compliance surveys conducted by OSHA at the site from 1973 to 1980. Data included 
reported/calculated 8-hr time-weighted average (TWA) and lead concentrations (mg/m3) for 
personal and area samples by department and operator codes. The exposure assessment for 
this study was based on 143 OSHA samples of personal air lead concentrations. Descriptive 
statistics were generated for each department by averaging each job title (within each 
department) and then taking the average of the job title averages over the department (Table 
II). Overall, the exposure assignments were refinements of the previous high/low lead strata, 
with the exception of the maintenance department. Maintenance was categorized as high 
lead exposure in the previous study; however, maintenance exposure levels were consistently 
lower than the other high lead departments in the current exposure assessment. For 
departments that were not sampled, a value of 0.06 mg/m3 was assigned since this was the 
lowest value measured and these departments were previously identified as having low 
exposure to lead. Cumulative lead exposure was calculated for each subject by multiplying 
the assigned exposure level by duration of employment within the department and summing 
over all jobs worked.
Exposures other than lead were also evaluated during the NIOSH 1975 visit. Workers in two 
departments (cadmium refinery and charge preparation) were determined to be highly 
exposed to cadmium; in particular, workers in the cadmium refinery had cadmium exposures 
well above the OSHA standard at the time. Person-time with 1 day or more of exposure in 
either of the two cadmium exposed departments was flagged for sensitivity analyses to 
control for possible confounding by cadmium.
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Standardized mortality ratio (SMR) analyses comparing the mortality experience of the 
cohort to that of several referent populations were conducted using the NIOSH Life Table 
Analysis System for Windows, LTAS.net [Schubauer-Berigan et al., 2011]. Person-time at 
risk began at the latest of the following dates: (i) 1 year after the first date of employment; 
(ii) the first day of employment 1940–1965; and (iii) the date the referent rate file began. 
Person-time ended at the earliest of the following dates: (i) the worker’s date of death for the 
deceased members of the cohort; (ii) the date last observed for those lost to follow-up; and 
(iii) December 31, 2013. Person-time at risk was stratified by age and calendar period (in 5-
year intervals) and multiplied by the corresponding rate in the reference population to 
generate expected numbers of deaths. The SMR was defined as the ratio of the observed to 
the expected number of deaths and were indirectly standardized based on age and calendar 
period. Reference rates were based on death rates for white males in the US population 
(1940–2011) for 92 cause-of-death categories [Robinson et al., 2006]. Because cancer and 
cardiovascular disease rates are lower in Idaho [CDC, 2016], and the smelter was located in 
Idaho and a large number of deaths occurred in Idaho (43%), we also considered death rates 
for the state of Idaho available for 119 cause-of-death categories (1960–2007). Multiple 
cause of death reference rates (1960–2011) that consider all causes listed on the death 
certificate were considered, especially for renal diseases and hypertension since these 
outcomes tend to appear on death certificates but not commonly as the underlying cause of 
death [Steenland et al., 1992]. Mortality from ALS was evaluated using underlying and 
multiple cause death rates for white males (1960–2009). For all rate files, the last calculated 
calendar-specific rate was used for all years after the last year of rate data.
Rate ratios (RR) were also calculated to internally compare the mortality experience of the 
cohort by exposure. For each outcome, the cohort was further stratified by cumulative lead 
exposure (0–<209 mg/m3-days; 209–<757 mg/m3-days; and 757+ mg/m3-days) and Poisson 
regression was performed controlling for age and calendar period with the 5 year categories. 
Exposure cut-points were selected so that approximately equal numbers of deaths occurred 
within each stratum. Due to the long latency of cancer mortality, exposures were lagged by 
10 years for cancer outcome analyses [Checkoway et al., 1990]. In all analyses, 95% 
confidence intervals (CIs) were calculated and for the RR analyses, a linear trend was 
performed by assigning the midpoint of the exposure categories and 1.5× the lower bound 
for the highest category. All analyses were also rerun excluding person-time with 1 day or 
more of exposure in two cadmium exposed departments to investigate possible confounding 
by cadmium. Results of this sensitivity analyses are presented in an on-line appendix 
(Appendix Tables S I and S II).
RESULTS
The cohort definition provided a study population of 1,990 white male hourly workers who 
contributed a total of 73,296 person-years at risk (Table I). By the end of the study follow-up 
period (December 31, 2013), 225 workers were alive (11%), 1,749 were deceased (88%), 
and only 16 (1%) were lost to follow-up. Analyses based on rate files beginning in 1960 
included 53,175 person-years at risk after January 1st, 1960 and excluded 198 deaths prior to 
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1960 and 10 workers with a date last observed prior to 1960. The 25 additional years of 
follow-up added 721 new deaths and cause of death information was available for over 97% 
of the known deaths.
Mortality results compared to the US (underlying and multiple cause) and Idaho (underlying 
only) populations are described in Table III for selected outcomes of interest. Table IV 
internally compares death rates across increasing strata of lead exposure.
There was a significant excess of lung cancer mortality (e.g., ID SMR = 1.94, CI: 1.64, 
2.27); however, lung cancer rates did not increase with estimated cumulative lead exposure. 
In addition, there were non-significant excesses of both stomach and kidney cancer 
mortality, but neither showed a positive exposure-response relation (in fact, stomach cancer 
and lung cancer rates ratios decreased with estimated cumulative lead exposure).
Mortality from cardiovascular disease and the subcategory cerebrovascular disease were 
found to be significantly elevated when compared to the Idaho referent population; in 
internal analyses, rate ratios for cardiovascular disease and cerebrovascular disease increased 
with estimated cumulative lead exposure. Mortality from hypertension without heart disease 
was elevated, particularly compared to the Idaho referent population (10 deaths, SMR = 
2.09, CI: 1.00, 3.84), and was in significant excess compared to the US referent population 
based on the multiple cause of death analysis (82 deaths, SMR = 1.34, CI: 1.06, 1.66); 
however, rate ratios for hypertension without heart disease did not increase with estimated 
cumulative lead exposure.
Renal disease was also more likely to be listed as a contributing cause on the death 
certificate with three underlying and 11 multiple-cause acute kidney disease deaths and 20 
underlying and 64 multiple-cause chronic kidney disease deaths. Mortality from acute 
kidney disease was not in excess. Mortality from chronic kidney disease (multiple cause 
analysis) was not elevated compared to the US referent population; however, rate ratios for 
chronic kidney disease increased with estimated cumulative lead exposure. This association 
disappeared in the sensitivity analysis excluding cadmium-exposed person-time (Appendix 
Table S II).
Only three ALS deaths were observed in the cohort with one additional death identified 
using contributing causes of death. ALS mortality was not elevated and due to the small 
number of deaths, an exposure-response analysis could not be performed.
Several outcomes not of a priori interest were elevated in the cohort. Suicide mortality was 
elevated (US SMR = 1.68 CI: 1.18, 2.33) as was both accidental falls and transportation 
accidents (ID SMR = 1.72, CI: 1.04, 2.69; ID SMR = 1.18, CI: 0.82, 1.65; respectively). In 
addition, an excess of nonmalignant respiratory diseases was found (ID SMR = 1.29, CI: 
1.11, 1.50), mostly due to the subcategory chronic obstructive pulmonary disease (COPD) 
(ID SMR = 1.43, CI: 1.18, 1.72) and pneumoconiosis and other respiratory diseases (ID 
SMR = 1.11 CI: 0.68, 1.72). However, neither nonmalignant respiratory diseases nor the 
subcategory COPD displayed a significant positive exposure-response, but pneumoconiosis 
and other respiratory diseases rates did increase with increasing exposure.
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Much of the research on the health effects of lead has historically focused on the acute 
effects of recent lead exposure, most notably cognitive impairment and acute kidney 
diseases. As lead exposure levels have declined, recent research has shifted focus to the 
longer-term, long-latency health effects from occupational exposure to lead [Schwartz and 
Hu, 2007].
In this update, using the new refined exposure assessment, analyses revealed significant 
positive trends in standardized rates for several causes of death. Specifically, increasing 
incremental levels of lead exposure were associated with higher rates of three a priori 
outcomes of interest: cardiovascular disease, cerebrovascular disease, and chronic kidney 
disease. Additionally, transportation accidents and pneumoconiosis and other respiratory 
diseases were found to be positively associated with increasing lead exposure.
The new refined exposure assessment also highlighted outcomes that had significantly 
higher overall rates when compared to the national and Idaho population rates but were not 
likely due to lead exposure. For example, there was a significant elevation of lung cancer 
deaths in this cohort, however, when lung cancer deaths were stratified by lead exposure, the 
exposure-response was found to be negative. Therefore, it is likely that the excess in lung 
cancer deaths observed is due to some potential confounder.
Potential confounders, such as arsenic, cadmium, and smoking were not controlled for in the 
previous follow-up of this study. Measurements taken during the NIOSH 1975 survey found 
that exposure to cadmium and arsenic were generally minor [Steenland et al., 1992], with 
the exception of two departments that were highly exposed to cadmium, one of which was a 
cadmium refinery. Sensitivity analyses removing person-time in these two cadmium 
departments did not change the results overall, with the exception of chronic kidney disease. 
Chronic kidney disease rates were no longer elevated and no longer increased with 
increasing exposure; however, RRs were elevated when compared to the lowest exposed 
referent group.
Smoking data on a sample of this cohort was collected for 173 of the 395 current workers in 
a cross-sectional survey conducted in May, 1976 where all departments were represented. 
An internal NIOSH reports indicate that at the time of the survey, 56.6% of the male workers 
were current smokers and 27.7% were former smokers. In comparison, the national male 
current smoking rate for 1974–1985 ranged between 33.5% and 43.4% [Fiore et al., 1989]. 
While no reliable smoking rates are available for Idaho for 1976, a 1985 population survey 
found Idaho to have the fourth lowest smoking rate in the US [Marcus et al., 1989]. The 
higher smoking rates of this cohort may explain some of the excess mortality figures from 
smoking-related causes of death, in particular the cancer outcomes, COPD and the 
cardiovascular diseases. Furthermore, the lack of a positive exposure response for the cancer 
outcomes and COPD indicates that excesses were for these outcomes were likely not due to 
lead exposure. In addition, while other studies have suggested a relationship between lead 
exposure and lung and stomach cancer, these findings were not consistent across studies 
[Steenland and Boffetta, 2000]. Also, reports by the DHHS [2007] and EPA [2006] based on 
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comprehensive reviews of the body of scientific literature essentially arrived at the same 
conclusion that even though many studies have reported low to moderate elevations in lung 
cancer mortality, the results are susceptible to confounding by smoking and other 
occupational exposures.
The kidney cancer results are consistent with a meta-analysis that examined cancer 
mortality/morbidity among eight highly lead-exposed cohorts (combined RR = 1.01; CI: 
0.72–1.42) [Steenland and Bofetta, 2000]. Few studies have supported a connection between 
lead exposure and kidney cancer, although two earlier case studies have observed renal 
tumors in workers with prolonged exposure to lead [Baker et al., 1980; Lilis, 1981].
Mortality from COPD was elevated when compared to both the national and Idaho rates; 
however, no trends in relation to levels of exposure were noted. Smoking is a significant risk 
factor for COPD, additionally, some of this cohort worked in underground mining prior to 
working at the smelter; underground mining is also a notable COPD risk factor [Selevan et 
al., 1985].
The kidney disease results are consistent with the significant body of research on lead 
nephrotoxicity, especially at high exposure levels in occupational settings [ATDSR, 2007]. 
Additionally, a study using population-based data reported increasing prevalence of chronic 
kidney disease with increasing blood lead levels (BLLs) in individuals with hypertension 
[Muntner et al., 2003].
Cardiovascular disease, hypertension, and cerebrovascular disease are also of particular 
interest because a cross-sectional population study found an exposure-response between lead 
and circulatory diseases [Lustberg and Silbergeld, 2002]. In adults, long-term exposure to 
lead has also been associated with an increased risk from hypertension and cerebrovascular 
disease, even at relatively low levels of lead exposure [Pirkle et al., 1985]. A meta-analysis 
of BLLs and blood pressure analyzing 31 diverse studies from a wide range of populations 
indicated mostly positive effects; blood lead was significantly associated with both higher 
systolic and diastolic blood pressure [Nawrot et al., 2002]. Similar results using meta-
analysis were found by Schwartz [1995] and [Staessen et al., 1994]. This is consistent with 
our cardiovascular and cerebrovascular disease results, and to a lesser extent our 
hypertension without heart disease results where mortality was elevated but did not 
demonstrate an exposure response. However, it is possible these results are confounded by 
smoking.
ALS was found to be elevated in previous studies of lead exposed individuals [Kamel et al., 
2002; Fang et al., 2009; Wang et al., 2014] with Wang [2009] noting an 81% increase in 
mortality. This cohort saw a slight excess in ALS deaths, however, due to the rarity of this 
outcome, this estimate was very imprecise.
While the previous follow-up also found excesses of accidents, the authors noted this was 
likely confounded by the high number of workers in the cohort who worked in the mining 
industry where accidents are more prevalent and not likely due to lead exposure. However, 
lead is a known neurotoxin and, in a population study, Min et al. [2012] found an association 
with blood lead and cadmium levels and balance dysfunction. In addition to an excess in 
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accidents, an excess in suicides was observed in this update; however, this excess was not 
associated with an exposure response.
Lastly, in addition to the limitations stated above regarding lack of control for potential 
confounders, it is important to also note the lack of complete work history information for 
159 individuals who were still employed when work histories were collected in 1975. This 
lack of complete information would result in potential exposure misclassification for these 
individuals. However, since the smelter ceased operation in 1982, at worst, exposure 
information is missing for 7 years for all 159 individuals resulting in 1,113 person-years of 
employment which would constitute less than 5% of all employed person-years.
In conclusion, this study observed an overall elevated mortality risk for the a priori causes of 
death of lung cancer, cardiovascular disease, cerebrovascular disease, and chronic kidney 
disease as well as for nonmalignant respiratory diseases, including COPD, accidental falls 
and transportation accidents. However, it is likely the excess in lung cancer, COPD and 
accidental falls were not due to lead exposure.
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Acknowledgments
FUNDING
Funded by the National Institute for Occupational Safety and Health. Approved by the CDC Human Subjects 
Review Board (#07-DSHEFS-01XP).
References
Baker EL, Goyer RA, Fowler BA, Khettry U, Bernard DB, Adler S, White RD, Babayan R, Feldman 
RG. Occupational lead exposure, nephropathy, and renal cancer. Am J Ind Med. 1980; 1:129–148. 
[PubMed: 7342760] 
Centers for Disease Control and Prevention (CDC), National Center for Health Statistics. Underlying 
Cause of Death 1999–2014 on CDC WONDER Online Database, released 2015. Data are from the 
Multiple Cause of Death Files, 1999–2014, as compiled from data provided by the 57 vital statistics 
jurisdictions through the Vital Statistics Cooperative Program. Nov 10 . 2016 http://wonder.cdc.gov/
ucd-icd10.html
Checkoway H, Pearce N, Hickey JL, Dement JM. Latency analysis in occupational epidemiology. Arc 
Environ Health. 1990; 45(2):95–100.
Ekong EB, Jaar BG, Weaver VM. Lead-related nephrotoxicity: A review of the epidemiologic 
evidence. Kidney Int. 2006; 70:2074–2084. [PubMed: 17063179] 
Fang F, Quinlan P, Ye W, Barber MK, Umbach DM, Sandler DP, Kamel F. Workplace exposures and 
the risk of amyotrophic lateral sclerosis. Environ Health Perspect. 2009; 9:1387–1392.
Fiore MC, Novotny TE, Pierce JP, Hatziandreu EJ, Patel KM, Davis RM. Trends in cigarette smoking 
in the United States: The changing influence of gender and race. Jama. 1989; 261(1):49–55. 
[PubMed: 2908994] 
Kamel F, Umbach DM, Munsat TL, Shefner JM, Hu H, Sandler DP. Lead exposure and amyotrophic 
lateral sclerosis. Epidemiology. 2002; 3:311–319.
Lilis R. Long term occupational lead exposure, chronic nephropathy, and renal cancer: A case report. 
Am J Ind Med. 1981; 2:293–297. [PubMed: 7345929] 
Bertke et al. Page 8













Lustberg M, Silbergeld E. Blood lead levels and mortality. Arch Intern Med. 2002; 162:2443–2449. 
[PubMed: 12437403] 
Marcus AC, Shopland DR, Crane LA, Lynn WR. Prevalence of cigarette smoking in the United States: 
Estimates from the 1985 current population survey. J Natl Cancer Inst. 1989; 81(6):409–414. 
[PubMed: 2783978] 
Min KB, Lee KJ, Park JB, Min JY. Lead and cadmium levels and balance and vestibular dysfunction 
among adult participants in the national health and nutrition examination survey (NHANES) 
1999– 2004. Environ Health Perspect. 2012; 120(3):413–417. [PubMed: 22214670] 
Muntner P, He J, Vupputuri S. Blood lead and chronic kidney disease in the general United States 
population: Results from NHANES III. Kidney Int. 2003; 63:1044–1050. [PubMed: 12631086] 
Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. Lead exposure and cardiovascular disease—
A systematic review. Environ Health Perspect. 2007; 115(3):472–482. [PubMed: 17431501] 
Nawrot T, Thijs L, Den Hond E, Roels HA, Staessen JA. An epidemiological re-appraisal of the 
association between blood pressure and blood lead: A meta-analysis. J Hum Hypertens. 2002; 
16:123–131. [PubMed: 11850770] 
Pirkle JL, Schwartz J, Landis JR, Harlan WR. The relationship between blood lead levels and blood 
pressure and its cardiovascular risk implications. Am J Epidemiol. 1985; 121:246–258. [PubMed: 
4014119] 
Robinson CF, Schnorr TM, Cassinelli RT II, Calvert GM, Steenland NK, Gersic CM, Schubauer-
Berigan MK. Tenth revision U.S. mortality rates for use with the NIOSH life table analysis system. 
J Occup Environ Med. 2006; 48(7):662–667. [PubMed: 16832222] 
Schubauer-Berigan MK, Hein MJ, Raudabaugh WM, Ruder AM, Silver SR, Spaeth S, Steenland K, 
Petersen MR, Waters KM. Update of the NIOSH Life table analysis system: A person-years 
analysis program for the windows computing environment. Am J Ind Med. 2011; 54:915–924. 
[PubMed: 22068723] 
Schwartz BS, Hu H. Adult lead exposure: Time for change. Environ Health Perspect. 2007; 3:451–454.
Schwartz J. Lead, blood pressure, and cardiovascular disease in men. Arch Environ Med. 1995; 50:31–
37.
Selevan S, Landrigan P, Stern F, Jones J. Mortality of lead smelter workers. Am J Epidemiol. 1985; 
122(4):673–683. [PubMed: 4025307] 
Staessen JA, Bulpitt CJ, Fagard R, Lauwerys RR, Roels H, Thijs L, Amery A. Hypertension caused by 
low-level lead exposure: Myth or fact? J Cardiovasc Risk. 1994; 1(1):87–97. [PubMed: 7614423] 
Steenland K, Boffetta P. Lead and cancer in humans: Where are we now? Am J Ind Med. 2000; 
38:295–299. [PubMed: 10940967] 
Steenland K, Selevan S, Landrigan P. The mortality of lead smelter workers: An update. Am J Public 
Health. 1992; 82(12):1641–1644. [PubMed: 1456339] 
U.S. Department of Health and Human Services (DHHS). Toxicological Profile for Lead (Update). 
Atlanta, GA: Public Health Service/ATSDR; 2007. 
U.S. Environmental Protection Agency (EPA). Air Quality Criteria for Lead—Final Report. 
Washington DC: EPA; 2006. EPA/600/R-05/144aF-bF
Wang MD, Gomes J, Cashman NR, Little J, Krewski D. A meta-analysis of observational studies of 
the association between chronic occupational exposure to lead and amyotrophic lateral sclerosis. J 
Occup Environ Med. 2014; 56(12):1235–1242. [PubMed: 25479292] 
Bertke et al. Page 9

























Bertke et al. Page 10
TABLE I
Lead Smelter Cohort Characteristics
Cohort size 1,990
Vital status (through12/31/2013)
 Deceased 1,749 (88%)
 Alive 225 (11%)
 Lost to follow-up 16 (1%)
Person years at risk (begin1/1/1940) 73,296
Year of birth, mean (range) 1916 (1867–1946)
Decade of first employment
 1900–1909 5 (<1%)
 1910–1919 53 (3%)
 1920–1929 162 (8%)
 1930–1939 264 (13%)
 1940–1949 873 (44%)
 1950–1959 510 (26%)
 1960–1969 123 (6%)
Duration of employment (years)
 1–<5 681 (34%)
 5–<10 419 (21%)
 10–<15 229 (12%)
 15–<20 189 (9%)
 20–<25 139 (7%)
 25–<30 108 (5%)
 30+ 225 (11%)

















NIOSH (1975) OSHA sampling (1973–1980)
Original lead exposure 
assessment No. samples
No. unique job titles 
sampled
Average lead TWA 
(mg/m3)a
Sinter plant, Lurgi High 13 6 2.34
Charge preparation High 26 11 1.68
Blast furnace High 23 8 1.25
Slag fuming furnace High 21 8 0.68
Lead refinery High 17 8 0.55
Cadmium refinery High 4 2 0.49
Silver refinery High 12 4 0.28
Materials recovery High 7 2 0.10
Concentrator Low 0 0 0.06b
Casting and loading Low 9 3 0.06
Electric furnace (hard lead) Low 0 0 0.06b
Quality control Low 0 0 0.06b
Maintenance High 11 4 0.06
Yard crew, labor pool, bull gang Low 0 0 0.06b
Total 143 56
a
Samples were first averaged over each unique job title, then the job title averages were again averaged within each department.
b
The concentrator, electric furnace, and quality control departments as well as the yard crew, labor pool, bull gang department were not sampled 
and so a value of 0.06 mg/m3wasassignedsincethiswastheaveragelevelsampledfor thecasting andloading department andthese 
departmentswerepreviouslygrouped together in the low grouping.
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